Changes in macrophage morphology in a Gaucher disease model are dependent on CTP:phosphocholine cytidylyltransferase α

Blood Cells, Molecules, and Diseases

Volumn 39, Issue 1, 2007, Pages 124-129

  Kacher, Yaacov ^a   Golan, Avner ^a   Pewzner Jung, Yael ^a   Futerman, Anthony H ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

CTP:phosphocholine cytidylyltransferase; Gaucher disease; Macrophages; Phospholipid

Indexed keywords

BROMOCONDURITOL; CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE; CHOLINE PHOSPHATE CYTIDYLYLTRANSFERASE ALPHA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL GROWTH; CELL SIZE; CELL ULTRASTRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DNA MODIFICATION; ENZYME ACTIVITY; ENZYME SYNTHESIS; FLUORESCENCE ACTIVATED CELL SORTING; GAUCHER DISEASE; HUMAN; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CELL SIZE; CELLS, CULTURED; CHOLINE-PHOSPHATE CYTIDYLYLTRANSFERASE; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; INOSITOL; MACROPHAGES; MICE; MICE, KNOCKOUT; PHOSPHATIDYLCHOLINES;

MUS;

EID: 34248536519     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2007.03.005     Document Type: Article

References (28)

1. Futerman A.H., and Zimran A. Gaucher Disease (2006), Taylor and Francis Group, Boca Raton
2. Beutler E., and Grabowski G.A. Gaucher disease. In: Scriver C.R., Valle D., Beaudet A., and Sly W.S. (Eds). The Metabolic and Molecular Bases of Inherited Disease (2001), McGraw-Hill, New York 3635-3668
3. Jmoudiak M., and Futerman A.H. Gaucher disease: pathological mechanisms and modern management. Br. J. Haematol. 129 (2005) 178-188
4. Futerman A.H., and van Meer G. The cell biology of lysosomal storage disorders. Nat. Rev., Mol. Cell Biol. 5 (2004) 554-565
5. Legler G., and Bieberich E. Active site directed inhibition of a cytosolic beta-glucosidase from calf liver by bromoconduritol B epoxide and bromoconduritol F. Arch. Biochem. Biophys. 260 (1988) 437-442
6. Premkumar L., Sawkar A.R., Boldin-Adamsky S., Toker L., Silman I., Kelly J.W., Futerman A.H., and Sussman J.L. X-ray structure of human acid-beta-glucosidase covalently bound to conduritol-B-epoxide. Implications for Gaucher disease. J. Biol. Chem. 280 (2005) 23815-23819
7. Yatziv S., Newburg D.S., Livni N., Barfi G., and Kolodny E.H. Gaucher-like changes in human blood-derived macrophages induced by beta-glucocerebrosidase inhibition. J. Lab. Clin. Med. 111 (1988) 416-420
8. Newburg D.S., Shea T.B., Yatziv S., Raghavan S.S., and McCluer R.H. Macrophages exposed in vitro to conduritol B epoxide resemble Gaucher cells. Exp. Mol. Pathol. 48 (1988) 317-323
9. Schwarz A., Rapaport E., Hirschberg K., and Futerman A.H. A regulatory role for sphingolipids in neuronal growth. Inhibition of sphingolipid synthesis and degradation have opposite effects on axonal branching. J. Biol. Chem. 270 (1995) 10990-10998
10. Trajkovic-Bodennec S., Bodennec J., and Futerman A.H. Phosphatidylcholine metabolism is altered in a monocyte-derived macrophage model of Gaucher disease but not in lymphocytes. Blood Cells Mol. Diseases 33 (2004) 77-82
11. Bodennec J., Pelled D., Riebeling C., Trajkovic S., and Futerman A.H. Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide. FASEB J. 16 (2002) 1814-1816
12. Jackowski S., and Fagone P. CTP:phosphocholine cytidylyltransferase: paving the way from gene to membrane. J. Biol. Chem. 280 (2005) 853-856
13. Kent C. CTP:phosphocholine cytidylyltransferase. Biochim. Biophys. Acta 1348 (1997) 79-90
14. Zhang D., Tang W., Yao P.M., Yang C., Xie B., Jackowski S., and Tabas I. Macrophages deficient in CTP:phosphocholine cytidylyltransferase-alpha are viable under normal culture conditions but are highly susceptible to free cholesterol-induced death. Molecular genetic evidence that the induction of phosphatidylcholine biosynthesis in free cholesterol-loaded macrophages is an adaptive response. J. Biol. Chem. 275 (2000) 35368-35376
15. Clausen B.E., Burkhardt C., Reith W., Renkawitz R., and Forster I. Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8 (1999) 265-277
16. Nociari M.M., Shalev A., Benias P., and Russo C. A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J. Immunol. Methods 213 (1998) 157-167
17. Kent C. Regulation of phosphatidylcholine biosynthesis. Prog. Lipid Res. 29 (1990) 87-105
18. Pastores G.M. Gaucher's disease. Pathological features. In: Zimran A. (Ed). Bailliere's Clin. Haematol. (1997) 739-749
19. Kojima M., and Sato T. Cytological characteristics of bone marrow reticular cells, tissue macrophages and monocytic cell line. Adv. Exp. Med. Biol. 121 (1979) 195-209
20. Clayton L. Tabers Cyclopedic Medical Dictionary (1989), F.A. Davis Company, Philadelphia PA
21. Bodennec J., Trajkovic-Bodennec S., and Futerman A.H. Simultaneous quantification of lyso-neutral glycosphingolipids and neutral glycosphingolipids by N-acetylation with [3H]acetic anhydride. J. Lipid Res. 44 (2003) 1413-1419
22. Lloyd-Evans E., Pelled D., Riebeling C., Bodennec J., de-Morgan A., Waller H., Schiffmann R., and Futerman A.H. Glucosylceramide and glucosylsphingosine modulate calcium mobilization from brain microsomes via different mechanisms. J. Biol. Chem. 278 (2003) 23594-23599
23. Pelled D., Trajkovic-Bodennec S., Lloyd-Evans E., Sidransky E., Schiffmann R., and Futerman A.H. Enhanced calcium release in the acute neuronopathic form of Gaucher disease. Neurobiol. Dis. 18 (2005) 83-88
24. Shiratori Y., Okwu A.K., and Tabas I. Free cholesterol loading of macrophages stimulates phosphatidylcholine biosynthesis and up-regulation of CTP:phosphocholine cytidylyltransferase. J. Biol. Chem. 269 (1994) 11337-11348
25. Rikitake Y., Hirata K., Yamashita T., Iwai K., Kobayashi S., Itoh H., Ozaki M., Ejiri J., Shiomi M., Inoue N., Kawashima S., and Yokoyama M. Expression of G2A, a receptor for lysophosphatidylcholine, by macrophages in murine, rabbit, and human atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 22 (2002) 2049-2053
26. Yang L.V., Radu C.G., Wang L., Riedinger M., and Witte O.N. Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A. Blood 105 (2005) 1127-1134
27. Kabarowski J.H., Zhu K., Le L.Q., Witte O.N., and Xu Y. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science 293 (2001) 702-705
28. Kacher Y., and Futerman A.H. Genetic diseases of sphingolipid metabolism: pathological mechanisms and therapeutic options. FEBS Lett. 580 (2006) 5510-5517